157 related articles for article (PubMed ID: 6315426)
21. In vivo activity of ceftriaxone (Ro 13-9904), a new broad-spectrum semisynthetic cephalosporin.
Beskid G; Christenson JG; Cleeland R; DeLorenzo W; Trown PW
Antimicrob Agents Chemother; 1981 Aug; 20(2):159-67. PubMed ID: 6269487
[TBL] [Abstract][Full Text] [Related]
22. Clavulanic acid in combination with ticarcillin: an in-vitro comparison with other beta-lactams.
Clarke AM; Zemcov SJ
J Antimicrob Chemother; 1984 Feb; 13(2):121-8. PubMed ID: 6323375
[TBL] [Abstract][Full Text] [Related]
23. The in vitro activity and beta-lactamase stability of cefpirome (HR 810), a pyridine cephalosporin agent active against staphylococci, Enterobacteriaceae and Pseudomonas aeruginosa.
Neu HC; Chin NX; Labthavikul P
Infection; 1985; 13(3):146-55. PubMed ID: 3928497
[TBL] [Abstract][Full Text] [Related]
24. In vitro activity of HR 756, a new cephalosporin compound.
Shah PM; Troche G; Stille W
J Antibiot (Tokyo); 1978 Nov; 31(11):1170-4. PubMed ID: 102631
[TBL] [Abstract][Full Text] [Related]
25. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1997). I. Susceptibility distribution].
Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Fujime M; Fujita K; Shigeta S; Watanabe J; Igari J; Ogiwara M; Ishibashi K; Oguri T; Yoshida H; Imafuku Y; Yamaguchi K; Matsumoto T; Kashitani F; Murai M; Ooe H; Nishikawa M; Watanabe K; Kobayashi Y; Uchida H; Oka T; Mochida C
Jpn J Antibiot; 1999 Feb; 52(2):93-129. PubMed ID: 10221177
[TBL] [Abstract][Full Text] [Related]
26. Susceptibility of gram-negative bacteria and Staphylococcus aureus to combinations of ticarcillin and clavulanic acid.
Casey P; Glauser M
Eur J Clin Microbiol; 1983 Dec; 2(6):541-7. PubMed ID: 6607834
[TBL] [Abstract][Full Text] [Related]
27. In vitro activity of SCE-2787, a new cephalosporin with potent activity against Pseudomonas aeruginosa and members of the family Enterobacteriaceae.
Klein O; Chin NX; Huang HB; Neu HC
Antimicrob Agents Chemother; 1994 Dec; 38(12):2896-901. PubMed ID: 7695279
[TBL] [Abstract][Full Text] [Related]
28. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
Jones RN; Sader HS; Fritsche TR; Pottumarthy S
Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
[TBL] [Abstract][Full Text] [Related]
29. GR-20263: a new aminothiazolyl cephalosporin with high activity against Pseudomonas and Enterobacteriaceae.
Verbist L; Verhaegen J
Antimicrob Agents Chemother; 1980 May; 17(5):807-12. PubMed ID: 6994640
[TBL] [Abstract][Full Text] [Related]
30. In vitro antimicrobial activity of cefotaxime, a new cephalosporin.
Masuyoshi S; Arai S; Miyamoto M; Mitsuhashi S
Antimicrob Agents Chemother; 1980 Jul; 18(1):1-8. PubMed ID: 6251749
[TBL] [Abstract][Full Text] [Related]
31. Effect of ceftriaxone on Pseudomonas aeruginosa and Staphylococcus aureus in broth, serum, and in combination with human polymorphonuclear leukocytes.
Bassler M; Blaschke H; Just M; Daschner FD
Chemotherapy; 1982; 28(5):390-6. PubMed ID: 6291868
[TBL] [Abstract][Full Text] [Related]
32. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1996)].
Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Shimizu Y; Terai T; Inoue H; Nakadate T; Ito C; Yoshida T; Ohno I; Tanno Y; Arakawa M; Igarashi K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Nakata K; Nakatani T; Inagawa H; Kusano N
Jpn J Antibiot; 1998 Jul; 51(7):437-74. PubMed ID: 9755430
[TBL] [Abstract][Full Text] [Related]
33. Comparative in vitro activity of cefepime against nosocomial isolates.
Sofianou D; Tsoulfa S; Kontodimou L; Polydorou F; Malaka E
J Chemother; 1997 Oct; 9(5):341-6. PubMed ID: 9373789
[TBL] [Abstract][Full Text] [Related]
34. Comparative activity of cefotaxime and selected beta-lactam antibiotics against Haemophilus influenzae and aerobic gram-negative bacilli.
Dabernat HJ; Delmas C
Rev Infect Dis; 1982; 4 Suppl():S401-5. PubMed ID: 6294790
[TBL] [Abstract][Full Text] [Related]
35. In vitro and in vivo antibacterial activities of FK037, a new parenteral cephalosporin.
Nishino T; Otsuki M; Hatano K; Nishihara Y
Chemotherapy; 1994; 40(3):167-82. PubMed ID: 8205935
[TBL] [Abstract][Full Text] [Related]
36. Antibacterial activity of ceftazidime (GR 20263) against routine hospital isolates and highly resistant strains of enterobacteriaceae and Pseudomonas aeruginosa.
Leigh DA; Nisbet D
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():107-10. PubMed ID: 19802975
[TBL] [Abstract][Full Text] [Related]
37. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1996). I. Susceptibility distribution].
Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Shigeta S; Takahashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Matsumoto T; Kashitani F; Kaku M; Ooe H; Mochida C
Jpn J Antibiot; 1998 Feb; 51(2):69-111. PubMed ID: 9575437
[TBL] [Abstract][Full Text] [Related]
38. Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.
Giamarellou H
Am J Med; 1986 Jun; 80(6B):126-37. PubMed ID: 3088998
[TBL] [Abstract][Full Text] [Related]
39. Susceptibility of 324 nonfermentative gram-negative rods to 6 cephalosporins and azthreonam.
Appelbaum PC; Tamim J; Pankuch GA; Aber RC
Chemotherapy; 1983; 29(5):337-44. PubMed ID: 6311492
[TBL] [Abstract][Full Text] [Related]
40. Canadian Multicenter Susceptibility Study, with a focus on cephalosporins, from 15 Canadian medical centers. The Canadian Multicenter Study Group.
Blondeau JM; Yaschuk Y
Antimicrob Agents Chemother; 1997 Dec; 41(12):2773-5. PubMed ID: 9420058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
